Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association

被引:0
|
作者
机构
来源
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:49 / 50
页数:2
相关论文
共 50 条
  • [21] A comparison of the ocular hypotensive effect of dorzolamide hydrochloride/timolol maleate to that of the concomitant therapy with brimonidine tartate and timolol malcate in patients with ocular hypertension or primary open-angle glaucoma.
    Sall, KN
    Johnson-Pratt, L
    Skobieranda, F
    Polis, A
    DeLucca, P
    Kolodny, A
    Fletcher, C
    Cassel, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S822 - S822
  • [22] Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension
    Kaluzny, Jozef
    Sobecki, Roman
    Czechowicz-Janicka, Krystyna
    Kecik, Dariusz
    Kaluzny, Bartlomiej J.
    Stewart, Jeanette A.
    Stewart, William C.
    ACTA OPHTHALMOLOGICA, 2008, 86 (08) : 860 - 865
  • [23] Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension
    Thomas Mundorf
    Robert J. Noecker
    Melissa Earl
    Advances in Therapy, 2007, 24 : 302 - 309
  • [24] Efficacy of the latanoprost versus timolol/dorzolamide combination therapy in patients with primary open angle glaucoma
    Rismanchian, Akram
    Eslami, Fateme
    Moeini, Heidarali
    Attarzade, Hosein
    Naderibeni, Afsane
    SAUDI MEDICAL JOURNAL, 2008, 29 (03) : 384 - 387
  • [25] Ocular blood flow and oxygen delivery to the retina in primary open-angle glaucoma patients: the addition of dorzolamide to timolol monotherapy
    Siesky, Brent
    Harris, Alon
    Kagemann, Larry
    Stefansson, Einar
    McCranor, Lynne
    Miller, Brian
    Bwatwa, Jeremiah
    Regev, Guy
    Ehrlich, Rita
    ACTA OPHTHALMOLOGICA, 2010, 88 (01) : 142 - 149
  • [26] Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension
    Mundorf, Thomas
    Noecker, Robert J.
    Earl, Melissa
    ADVANCES IN THERAPY, 2007, 24 (02) : 302 - 309
  • [27] Comparison of Dorzolamide/Timolol and Latanoprost/Timolol Fixed Combinations on Diurnal Intraocular Pressure Control in Primary Open-Angle Glaucoma
    Eren, Mumin Hakan
    Gungel, Hulya
    Altan, Cigdem
    Pasaoglu, Isil Basgil
    Sabanci, Senol
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 28 (04) : 381 - 386
  • [28] Persistency with latanoprost or timolol in primary open-angle glaucoma suspects
    Schwartz, GF
    Reardon, G
    Mozaffari, E
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 : S13 - S16
  • [29] Latanoprost, brimonidine and dorzolamide used as adjunctive therapy added to β-blocker therapy in ocular hypotensive and primary open-angle glaucoma patients
    Leech, JN
    Sharpe, ED
    Lee, WH
    Kolker, AE
    Day, DG
    Stewart, WC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S665 - S665
  • [30] Comparison of the Efficacy of Latanoprost, Bimatoprost and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
    Colak, Nur
    Horozoglu, Fatih
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2008, 38 (06): : 473 - 480